<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002140'>Ischemic stroke</z:hpo> causes cell <z:mp ids='MP_0001651'>necrosis</z:mp> with the exposure of extracellular <z:chebi fb="3" ids="33697">ribonucleic acid</z:chebi> (<z:chebi fb="40" ids="33697">RNA</z:chebi>) and other intracellular material </plain></SENT>
<SENT sid="1" pm="."><plain>As shown recently, extracellular <z:chebi fb="40" ids="33697">RNA</z:chebi> impaired the blood-brain-barrier and contributed to vasogenic <z:hpo ids='HP_0000969'>edema</z:hpo>-formation </plain></SENT>
<SENT sid="2" pm="."><plain>Application of ribonuclease 1 (RNase 1) diminished <z:hpo ids='HP_0000969'>edema</z:hpo>-formation and also reduced lesion volume in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we investigate whether reduction of lesion volume is due to the reduction of <z:hpo ids='HP_0000969'>edema</z:hpo> or of other neuroprotective means </plain></SENT>
<SENT sid="4" pm="."><plain>Neuroprotective and <z:hpo ids='HP_0000969'>edema</z:hpo> protective effects of RNase 1 pretreatment were assessed using a temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model in rats </plain></SENT>
<SENT sid="5" pm="."><plain>Lesion volume was assessed on magnetic resonance imaging (MRI) </plain></SENT>
<SENT sid="6" pm="."><plain>T2-relaxation-time and midline-shift as well as brain water content (wet-dry-method) were measured to quantify <z:hpo ids='HP_0000969'>edema</z:hpo> formation </plain></SENT>
<SENT sid="7" pm="."><plain>The impact of <z:hpo ids='HP_0000969'>edema</z:hpo> formation on <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was evaluated in craniectomized animals </plain></SENT>
<SENT sid="8" pm="."><plain>Exogenous RNase 1 was well tolerated and reduced <z:hpo ids='HP_0000969'>edema</z:hpo>-formation and <z:mpath ids='MPATH_124'>infarct</z:mpath> size (26.7% +/- 10.7% vs. 41.0% +/- 10.3%; p&lt;0.01) at an optimal dose of 42 microg/kg as compared to placebo </plain></SENT>
<SENT sid="9" pm="."><plain>Craniectomized animals displayed a comparable <z:hpo ids='HP_0000969'>edema</z:hpo> reduction but no reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="10" pm="."><plain>The present study introduces a hitherto unrecognized mechanism of ischemic brain damage and a novel neuroprotective approach towards <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> treatment </plain></SENT>
</text></document>